Featured Research

from universities, journals, and other organizations

Fattening pollutants? Chemicals in mother’s blood contribute to child’s obesity, study suggests

Date:
October 6, 2010
Source:
Environmental Health Perspectives (NIEHS)
Summary:
Babies whose mothers had relatively high levels of the chemical DDE in their blood were more likely to both grow rapidly during their first 6 months and to have a high body mass index (BMI) by 14 months, according to scientists. DDE, an endocrine disruptor, is a by-product of the pesticide DDT.

Babies whose mothers had relatively high levels of the chemical DDE in their blood were more likely to both grow rapidly during their first 6 months and to have a high body mass index (BMI) by 14 months, according to a team of scientists based in Barcelona, Spain. DDE, an endocrine disruptor, is a by-product of the pesticide DDT.

Published online October 5 ahead of print in the peer-reviewed journal Environmental Health Perspectives (EHP), the study examined data collected between 2004 and 2006 on a representative sample of 518 Spanish women in their first trimester of pregnancy. Among babies whose mothers were normal weight pre-pregnancy, those babies whose mothers had DDE levels in the top 75 percent of exposure were twice as likely to grow rapidly during their first 6 months as babies whose mothers had the lowest DDE levels. Infants in the top 50 percent of exposure were three times more likely to have high BMI scores at 14 months. The researchers did not observe an association between DDE and weight for babies of mothers who were overweight before pregnancy.

Two other human studies have shown an association between prenatal DDE exposure and obesity later in life. "However, this analysis suggests, to our knowledge for the first time, that fetal DDE exposure may promote rapid growth starting in the immediate postnatal period," report lead author and epidemiologist Michelle A. Mendez, of the Centre for Research in Environmental Epidemiology, and her colleagues. Laboratory studies have suggested that "exposure to chemicals with endocrine-disrupting properties might promote shifts in appetite regulation, but may also promote obesity through metabolic changes," says Mendez.

Only 14 percent of all the children had a BMI exceeding the 85th percentile, but rapid growers of both normal-weight and overweight mothers were five times more likely than other babies to have a high BMI at 14 months. Other studies have shown that infants who grow rapidly also tend to have higher levels of body fat. More than 40 studies have associated rapid weight gain in the first few months of life with obesity and metabolic disorders later in life, the team writes.

The team tested the mothers' blood serum for other organochlorine compounds with endocrine-disrupting properties, including polychlorinated biphenyls (PCBs), but these chemicals showed no association with early weight gain. The researchers controlled for other factors in rapid growth and high BMI, such as parents' height and weight, duration of breastfeeding, and whether the mother smoked. The team is continuing to study the children, who are now 4 years old.

"Most of the exposure to organochlorine compounds is thought to come from the diet," says Mendez. Foods including meats, fish, dairy products, and fruits and vegetables are potential sources of exposure to DDE and similar compounds. "These chemicals persist in the environment as they are highly resistant to degradation," Mendez says.


Story Source:

The above story is based on materials provided by Environmental Health Perspectives (NIEHS). Note: Materials may be edited for content and length.


Journal Reference:

  1. Michelle A. Mendez, Raquel Garcia-Esteban, M?nica Guxens, Martine Vrijheid, Manolis Kogevinas, Fernando Go?i, Silvia Fochs, Jordi Sunyer. Prenatal Organochlorine Compound Exposure, Rapid Weight Gain and Overweight in Infancy. Environmental Health Perspectives, 2010; DOI: 10.1289/ehp.1002169

Cite This Page:

Environmental Health Perspectives (NIEHS). "Fattening pollutants? Chemicals in mother’s blood contribute to child’s obesity, study suggests." ScienceDaily. ScienceDaily, 6 October 2010. <www.sciencedaily.com/releases/2010/10/101006115745.htm>.
Environmental Health Perspectives (NIEHS). (2010, October 6). Fattening pollutants? Chemicals in mother’s blood contribute to child’s obesity, study suggests. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/10/101006115745.htm
Environmental Health Perspectives (NIEHS). "Fattening pollutants? Chemicals in mother’s blood contribute to child’s obesity, study suggests." ScienceDaily. www.sciencedaily.com/releases/2010/10/101006115745.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins